Several possible studies
Story checked
“How I Took Control of My Weight Loss Journey” (opens in a new tab)
menshealth.com · 2026-10-08
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
“How I Took Control of My Weight Loss Journey”
menshealth.com · 2026-10-08
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedThe story says that after years of trying, a weight management medication finally helped the writer lose weight and keep it off.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 4Not checkedThe writer says that in late 2022 his doctor brought up Wegovy (semaglutide) injection 2.4 mg alongside exercise and diet changes he was already making.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 4Not checkedThe story says Wegovy helped reduce appetite so he could eat smaller portions, feel full sooner, and continue losing weight while also increasing physical activity.View evidenceHide evidence
As stateda pound or two
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 4Not checkedThe writer says his weight-loss motivation shifted from his two boys to his wife, who became his ongoing reason for maintaining progress.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Direct Coronary Vascular and Lipidomic Remodeling by Low-Dose GLP-1 Agonist Therapy in Cardiometabolic HFpEF.
Research Square · 2026 · PubMed
Review for "Semaglutide 25 mg Oral versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes"
2026 · Crossref
Predictors of treatment response to semaglutide for weight management.
Frontiers in Endocrinology · 2026 · PubMed, Europe PMC
Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial.
Diabetes, Obesity & Metabolism · 2026 · PubMed
Post-Initiation Care Patterns and Weight Loss With Semaglutide and Tirzepatide for Obesity in Clinical Practice
2026 · Europe PMC
And 10 more candidates considered.